Royalty Report: Consumer Goods, Retail & Leisure, Drugs – Collection: 6530

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Consumer Goods
  • Retail & Leisure
  • Drugs
  • Personal Care Products

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 6530

License Grant
The Company of Israel and the Canadian Licensee restructured its Marketing Agreement surrounding purEffectTM a four-step acne treatment system.
License Property
Product – For the purposes of this agreement, the purEffect® product shall consist of all raw materials, formulas, formulations, research, studies, clinical tests, monographs, packaging, designs, logos, typestyles, trademarks, copyrights, other intellectual property rights and all other elements and information relating to the purEffect® acne and/or skin care products.
Field of Use
The rights granted apply to skin care market relating to the healthcare industry.

IPSCIO Record ID: 3359

License Grant
The Company licensed the marketing rights for purEffectTM, a four-step acne treatment system.

An emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products, today announced that it has restructured its Marketing Agreement with the Company's joint venture marketing partner for purEffectTM, a four-step acne treatment system.  The restructured agreement includes a royalty.

License Property
The purEffect four-step acne treatment includes the Purifying Cleanser, Electrolyte Toner, Intensive Repair Lotion, and the Healing Cream.
Field of Use
The use in acne treatment.

IPSCIO Record ID: 4432

License Grant
The Licensor grants to the Canadian Licensee the sole and exclusive right and license to manufacture, produce, package, distribute, market, promote, use and sell the products in the territory, and the sole and exclusive right and license to use the formulas, know-how, intellectual property and any improvements or technical developments of the formula, know-how or intellectual property known as Neuroskin, Neuro Skin, Itch-X, Dermac, Neosin, Optiwash and Vitum.
License Property
Neuroskin is a steroid-free therapeutic skin care product, utilizing its unique nano-fine mineral technology, which treats minor skin irritations.

IPSCIO Record ID: 1533

License Grant
The Licensor and Licensee have entered into a 5-year agreement, renewable by Licensee for successive 5-year periods, for the license of the Banana Boat®  trade name,  patent, product formulation and other proprietary information.
License Property
Banana Boat offers an extensive line of sun care products designed for specific uses, such as sun protection in SPFs from 4 to 50, waterproof and sweat proof formulas and infant and children's products.  Banana Boat also sells a variety of skin care products, including sunless tanning lotion, after-sun products, moisturizers and skin treatment formulas containing additives such as Vitamin E and Aloe Vera.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.